Treatment of Breast Cancer-Related Lymphedema With Topical Tacrolimus: A Prospective, Open-Label, Single-Arm, Phase II Pilot Trial

PURPOSE: Breast cancer-related lymphedema (BCRL) is a chronic, progressive side effect of breast cancer treatment, occurring in one-third of patients treated with axillary lymph node dissection and nodal radiotherapy. Cluster of differentiation 4-positive (CD4(+)) cells plays a key role in BCRL by f...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulmark Hansen, Frederik C., Jørgensen, Mads Gustaf, Sørensen, Jens Ahm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981991/
https://www.ncbi.nlm.nih.gov/pubmed/36762782
http://dx.doi.org/10.4048/jbc.2023.26.e2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981991/
https://www.ncbi.nlm.nih.gov/pubmed/36762782
http://dx.doi.org/10.4048/jbc.2023.26.e2

Ejemplares similares